Current NBCC members have access to live webinars led by some of the leading scientists, researchers, and advocates in the breast cancer field.
Topics include updates on current breast cancer research, clinical trials, issues of disparities in the breast cancer space, NBCC’s public policy work, and many more.
When the Cost of Cancer Care Becomes a Toxicity—What Can Be Done About It
Date: October 29, 2026; 3 pm ET
Speaker: Fumiko Chino, MD, Cancer researcher and Associate Professor in Breast Radiation Oncology at MD Anderson Cancer Center.
The financial burden of cancer care can have profound effects on patients and their families—and can influence treatment decisions, quality of life, and outcomes. Join Dr. Fumiko Chino for a discussion of financial toxicity in breast cancer, who is most at risk, and what can be done to address it. We’ll also explore how breast cancer advocates can help drive change through research, clinical trials, health policy, and efforts to make cancer care more affordable and accessible.
The Price of Innovation: How Cancer Drug Prices Affect Access
Date: Monday, November 16; 12 PM EDT
Speakers: Lee Newcomer, MD, Former Chief Medical Officer, SVP Oncology and Genetics, UnitedHealthcare, Lee N. Newcomer Consulting, LLC; Daniel Goldstein, MD, Professor of Oncology, Internal Medicine, and Health Economics, Tel Aviv University
New cancer treatments can offer meaningful advances—but increasingly high drug prices raise difficult questions about affordability and access. NBCC joins Dr. Lee Newcomer and Dr. Daniel Goldstein for a discussion of why cancer drugs launch at the prices they do in the United States, how the current system might better reward meaningful innovation while ensuring access to effective treatments, and what U.S. pricing means for patients and health systems around the world. The conversation will also explore how breast cancer advocates can help push for a more rational, affordable, and accessible system of cancer care.
On August 21, NBCC welcomed Drs. Oluwasegun Akinyemi, Miriam Michael, Robin Williams, and Shari Lawson for a discussion of their recent JAMA Network Open study examining whether expanding Medicaid under the Affordable Care Act was associated with better survival for women with breast cancer. The researchers analyzed nearly 1.6 million women ages 40–64 diagnosed with breast cancer between 2006 and 2021, comparing outcomes in states that expanded Medicaid with those that did not. They found that Medicaid expansion was associated with a 4.8% lower risk of death overall and an absolute 1.4 percentage-point reduction in mortality at five years—equivalent to about 1,400 fewer deaths for every 100,000 women with breast cancer.
Watch as Dr. Sarah Lima discusses how historic redlining continues to shape disparities in breast cancer risk and survival today. Drawing on findings from her doctoral research at the University at Buffalo, Dr. Lima made a compelling case that breast cancer outcomes cannot be fully understood—or addressed—without grappling with the legacy of structural racism and disinvestment.
See below for a list of NBCC’s past webinars. If you are interested in viewing a recording of one or more of the presentations, please contact Skye Wilson. Please note that recordings are only available to current members of NBCC. You can renew your membership here.
